NRX Pharmaceuticals (NRXP) Q4 2022 Earnings

30MarConfirmed
May 22
Aug 22
Q3 2022
Q4 2022
-0.21
-0.17
-0.14
-0.1

Details

Expected EPS
-0.14
Actual EPS
-0.16
Surprise EPS
-0.02
Surprise Percent
+14.29%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.16 per share for Q4 2022.

0 Comments

Share your thoughts